Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results

Health Services Research

Volumn 46, Issue 6 PART 1, 2011, Pages 1762-1777

  Howard, David H ^a   Kenline, Carolyn ^a   Lazarus, Hillard M ^b   Lemaistre, Charles F ^c   Maziarz, Richard T ^d   McCarthy Jr , Philip L ^e   Parsons, Susan K ^f   Szwajcer, David ^g   Douglas Rizzo, James ^h   Majhail, Navneet S ⁱ  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Texas Institute of Medicine and Surgery   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g UNIVERSITY OF MANITOBA   (Canada)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

clinical practice patterns guidelines resource use evidence based practice; hospitals; Technology adoption diffusion use

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER TRANSPLANTATION; CELL TRANSPLANTATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC CELL; HUMAN; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; TEACHING HOSPITAL; TREND STUDY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFORMATION DISSEMINATION; PHYSICIAN'S PRACTICE PATTERNS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 81755184338     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2011.01296.x     Document Type: Article

References (22)

1. Antman, K., and, R. P. Gale,. 1988. " Advanced Breast Cancer: High-Dose Chemotherapy and Bone Marrow Autotransplants. Annals of Internal Medicine 108 (4): 570-4.
2. Berry, D. A., G. Broadwater, J. P. Klein, K. Antman, J. Aisner, J. Bitran, M. Costanza, C.O. Freytes, E. Stadtmauer, R.P. Gale, I. C. Henderson, H.M. Lazarus, P.L. McCarthy, Jr,., L. Norton, H. Parnes, A. Pecora, M.C. Perry, P. Rowlings, G. Spitzer, and, M. M. Horowitz,. 2002. " High-Dose versus Standard Chemotherapy in Metastatic Breast Cancer: Comparison of Cancer and Leukemia Group B Trials with Data from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology 20 (3): 743-50.
3. Bezwoda, W. R., L. Symour, and, R. D. Dansey,. 1995. " High-Dose Chemotherapy with Hematopoietic Rescue as Primary Treatment for Metastatic Breast Cancer: A Randomized Controlled Trial. Journal of Clinical Oncology 13 (10): 2483-9.
4. Congressional Budget Office. 2007. Research on the Comparative Effectiveness of Medical Treatments. Publication number 2975. Washington, DC: Congressional Budget Office.
5. Duffy, S. Q., and, D. E. Farley,. 1992. " The Protracted Demise of Medical Technology: The Case of Intermittent Positive Pressure Breathing. Medical Care 30 (8): 718-36.
6. Eddy, D. M., 1992. " High-Dose Chemotherapy with Autologous Bone Marrow Transplantation for the Treatment of Metastatic Breast Cancer. Journal of Clinical Oncology 10 (4): 657-70.
7. Farquhar, C., J. Marjoribanks, R. Basser, S. E. Hetrick, and, A. Lethaby,. 2005a. " High Dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation versus Conventional Chemotherapy for Women with Metastatic Breast Cancer. Cochrane Database of Systematic Reviews Issue 3. Art. No.: CD003142.
8. Farquhar, C., J. Marjoribanks, R. Basser, and, A. Lethaby,. 2005b. " High Dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation versus Conventional Chemotherapy for Women with Early Poor Prognosis Breast Cancer. Cochrane Database of Systematic Reviews Issue Issue 3. Art. No.: CD003139.
9. Huizenga, H. F., S. D. Ramsey, and, R. K. Albert,. 1998. " Estimated Growth of Lung Volume Reduction Surgery among Medicare Enrollees: 1994 to 1996. Chest 114 (6): 1583-7. (Pubitemid 128487479)
10. The IPPB Trial Group. 1983. " Intermittent Positive Pressure Breathing Therapy of Chronic Obstructive Pulmonary Disease: A Clinical Trial. Annals of Internal Medicine 99 (5): 612-20.
11. Mello, M. M., and, T. A. Brennan,. 2001. " The Controversy over High-Dose Chemotherapy with Autologous Bone Marrow Transplant for Breast Cancer. Health Affairs 20 (5): 101-17. (Pubitemid 33710344)
12. National Cancer Institute. 2010. "NCCN Research & Business Resources, NCCN Member Institutions" [accessed on September 21, 2010]. Available at
13. National Emphysema Treatment Trial Research Group. 2003. " A Randomized Trial Comparing Lung-Volume Reduction Surgery with Medical Therapy for Severe Emphysema. New England Journal of Medicine 348 (21): 2059-73.
14. Naunheim, K. S., 2007. " Lung-Volume Reduction Surgery: A Vanishing Operation? Journal of Thoracic and Cardiovascular Surgery 133 (6): 1412-3.
15. Peters, W. P., M. Ross, J. J. Vredenburgh, B. Meisenberg, L. B. Marks, E. Winer, J. Kurtzberg, R.C. Bast, Jr,., R. Jones, and, E. Shpall,. 1993. " High-Dose Chemotherapy and Autologous Bone Marrow Support as Consolidation after Standard-Dose Adjuvant Therapy for High-Risk Primary Breast Cancer. Journal of Clinical Oncology 11 (6): 1132-43. (Pubitemid 23163355)
16. RAND. 2010. "Analysis of Comparative Effectiveness Research" [accessed on November 29, 2010]. Available at
17. Rettig, R. A., P. D. Jacobson, C. M. Farquhar, and, W. M. Aubry,. 2007. False Hope: Bone Marrow Transplantation for Breast Cancer. New York: Oxford University Press.
18. Rodenhuis, S., D. J. Richel, E. van der Wall, J. H. Schornagel, J. W. Baars, C. C. Koning, J. L. Peterse, J. H. Borger, W. J. Nooijen, R. Bakx, O. Dalesio, and, E. Rutgers,. 1998. " Randomised Trial of High-Dose Chemotherapy and Haemopoietic Progenitor-Cell Support in Operable Breast Cancer with Extensive Axillary Lymph-Node Involvement. Lancet 352 (9127): 515-21. (Pubitemid 28372224)
19. Rye, C. B., and, J. R. Kimberly,. 2007. " Adoption of Innovations by Provider Organizations in Health Care. Medical Care Research and Review 64 (3): 235-78. (Pubitemid 46762942)
20. Schellenbach, J., 1999. "Breast Cancer and Bone Marrow Transplantation" [accessed on November 1, 2010]. Available at
21. VanLare, J. M., P. H. Conway, and, H. C. Sox,. 2010. " Five Next Steps for a New National Program for Comparative Effectiveness Research. New England Journal of Medicine 362 (11): 970-3.
22. Weiss, R.B, R. M. Rifkin, F. M. Stewart, R. L. Theriault, L. A. Williams, A. A. Herman, and, R. A. Beveridge,. 2000. " High-Dose Chemotherapy for High-Risk Primary Breast Cancer: An On-Site Review of the Bezwoda Study. Lancet 355 (9208): 999-1003.